Atlas Trials

Study to Evaluate Drug-Drug Interaction Between IDX719 and Simeprevir in Healthy Participants (MK-1894-004)

Clinical trial NCT01813513 · COMPLETED

Trial details

NCT number
NCT01813513
Sponsor
Merck Sharp & Dohme LLC
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Chronic Hepatitis C Infection
Start date
2013-01-01
Primary completion
2013-07-01
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.